IL313353A - Antimalarial agents - Google Patents

Antimalarial agents

Info

Publication number
IL313353A
IL313353A IL313353A IL31335324A IL313353A IL 313353 A IL313353 A IL 313353A IL 313353 A IL313353 A IL 313353A IL 31335324 A IL31335324 A IL 31335324A IL 313353 A IL313353 A IL 313353A
Authority
IL
Israel
Prior art keywords
antimalarial agents
antimalarial
agents
Prior art date
Application number
IL313353A
Other languages
Hebrew (he)
Original Assignee
Merck Sharp & Dohme Llc
Msd R& D China Co Ltd
Walter & Eliza Hall Inst Medical Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CN2021/136177 external-priority patent/WO2023102747A1/en
Application filed by Merck Sharp & Dohme Llc, Msd R& D China Co Ltd, Walter & Eliza Hall Inst Medical Res filed Critical Merck Sharp & Dohme Llc
Publication of IL313353A publication Critical patent/IL313353A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/529Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim forming part of bridged ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL313353A 2021-12-07 2022-12-05 Antimalarial agents IL313353A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/CN2021/136177 WO2023102747A1 (en) 2021-12-07 2021-12-07 Antimalarial agents
US202263397614P 2022-08-12 2022-08-12
PCT/US2022/051770 WO2023107356A1 (en) 2021-12-07 2022-12-05 Antimalarial agents

Publications (1)

Publication Number Publication Date
IL313353A true IL313353A (en) 2024-08-01

Family

ID=85150731

Family Applications (1)

Application Number Title Priority Date Filing Date
IL313353A IL313353A (en) 2021-12-07 2022-12-05 Antimalarial agents

Country Status (12)

Country Link
EP (1) EP4444722A1 (en)
KR (1) KR20240113588A (en)
AU (1) AU2022404966A1 (en)
CA (1) CA3240145A1 (en)
CO (1) CO2024007160A2 (en)
CR (1) CR20240239A (en)
DO (1) DOP2024000108A (en)
IL (1) IL313353A (en)
MX (1) MX2024006878A (en)
PE (1) PE20241517A1 (en)
TW (1) TWI842251B (en)
WO (1) WO2023107356A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021155612A1 (en) * 2020-02-09 2021-08-12 Merck Sharp & Dohme Corp. Antimalarial agents

Also Published As

Publication number Publication date
KR20240113588A (en) 2024-07-22
AU2022404966A1 (en) 2024-06-13
CA3240145A1 (en) 2023-06-15
PE20241517A1 (en) 2024-07-19
TWI842251B (en) 2024-05-11
CR20240239A (en) 2024-07-08
EP4444722A1 (en) 2024-10-16
DOP2024000108A (en) 2024-07-15
TW202334161A (en) 2023-09-01
WO2023107356A1 (en) 2023-06-15
CO2024007160A2 (en) 2024-07-18
MX2024006878A (en) 2024-08-15

Similar Documents

Publication Publication Date Title
EP4114862A4 (en) Anti-ccr8 agents
CA199411S (en) Handshower
EP3895679C0 (en) Handheld-rehabilitation-device
EP4100401A4 (en) Antimalarial agents
IL290525A (en) Antimalarial agents
CA207519S (en) Smartglasses
EP4061375A4 (en) Antimalarial agents
EP4077308C0 (en) Anti-malarial agents
CA198107S (en) Protractor-ruler
IL313353A (en) Antimalarial agents
GB202004914D0 (en) Mirco-nozzle
GB202017642D0 (en) Therapeputic agents
CA212416S (en) Aéronef
DK4001080T3 (en) Lasthjul
CA207517S (en) Smartglasses
CA207518S (en) Smartglasses
CA207516S (en) Smartglasses
CA206631S (en) Mandoline
CA204810S (en) Playard
CA204263S (en) Brushguard
CA203904S (en) Mandoline
CA201360S (en) Débardeur
CA200872S (en) Nighstand
CA200456S (en) Hoodie
CA200353S (en) Balaclava